HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dopaminergic drug therapy in patients with hyperprolactinemia that is difficult to treat.

AuthorsR J Pepperell
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 626 Pg. 431-7 ( 1991) ISSN: 0077-8923 [Print] United States
PMID1676255 (Publication Type: Journal Article)
Chemical References
  • Dopamine Agents
Topics
  • Adenoma (therapy)
  • Dopamine Agents (adverse effects, therapeutic use)
  • Endocrine Glands (physiopathology)
  • Female
  • Humans
  • Hyperprolactinemia (complications, drug therapy, physiopathology)
  • Osteoporosis, Postmenopausal (etiology, prevention & control)
  • Pituitary Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: